Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday ...

Recent research suggests that Ozempic and other GLP-1 receptor agonists, commonly used for weight loss, may offer unexpected ...

China Is Focusing On Next-Level AGI I’m 81 with $240K in mutual funds, no debt and living in a condo I’ve fully paid for. But am I ready for a major financial downturn? Supreme Court rules against ...

Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover ...

The cost of illegal immigration is a hot-button issue – and Democrats have a wide range of reactions. In this video, we break down how Democratic leaders and voters are responding to the economic, ...

JPMorgan Chase investors will be keen to learn how the largest U.S. lender and the world's biggest economy are likely to be ...

Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a cultural and medical shift. I ...

CEO resigns as Eli Lilly (LLY) dominates the weight loss drug market and compounders threaten the company's financial outlook ...

Wall Street stocks rose again Friday, adding to weekly gains fueled by deescalation of the China-US trade war and hopes for ...

Global stock markets struggled for direction on Friday as they sought to hold onto weekly gains fuelled by the China-US trade ...

For the last few months, not a day has gone by where tariffs haven’t been on the tip of everyone’s tongue. The economic ...

Stocks closed solidly higher on Friday, pushing major indexes to big weekly gains for the third time in the last four weeks.